Status:

RECRUITING

Structural Modification In Supraglottic Airway Device

Lead Sponsor:

The Cleveland Clinic

Conditions:

Airway Complication of Anesthesia

Ventilation Therapy; Complications

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

The proposed A/Z modification of a supraglottic airway (SGA) incorporates an opening in the SGA body that enables access to the endotracheal tube (ETT) through the body of the SGA without the need of ...

Detailed Description

The special design allows conversion of a telescopic coaxial portion (R piece), replacing with an ETT which can act coaxially to provide both supraglottic (up position) and endotracheal (down position...

Eligibility Criteria

Inclusion

  • Adult patients
  • scheduled for a general anesthesia procedure with ETT \& muscle relaxation

Exclusion

  • Patients who are not able to consent
  • Non English Speaking
  • History of difficult airway
  • Physical exam of airway which suggests difficulty in airway management or need to use special equipment
  • BMI \>35
  • Gastroesophageal reflux disease
  • Anesthetic plan other than general anesthesia
  • Emergency procedures

Key Trial Info

Start Date :

September 30 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04498598

Start Date

September 30 2020

End Date

December 31 2025

Last Update

May 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195

Structural Modification In Supraglottic Airway Device | DecenTrialz